Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature

Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug‐drug interactions. Randomized controlled trials are needed to further demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokr, Mohamed, Ahmed, Abdelrahman, Abubakar, Hossam, Sayedahmad, Ziad, Rashed, Ahmed, Afonso, Luis, Cardozo, Shaun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332814/
https://www.ncbi.nlm.nih.gov/pubmed/30656027
http://dx.doi.org/10.1002/ccr3.1917
_version_ 1783387434672717824
author Shokr, Mohamed
Ahmed, Abdelrahman
Abubakar, Hossam
Sayedahmad, Ziad
Rashed, Ahmed
Afonso, Luis
Cardozo, Shaun
author_facet Shokr, Mohamed
Ahmed, Abdelrahman
Abubakar, Hossam
Sayedahmad, Ziad
Rashed, Ahmed
Afonso, Luis
Cardozo, Shaun
author_sort Shokr, Mohamed
collection PubMed
description Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug‐drug interactions. Randomized controlled trials are needed to further demonstrate their efficacy and safety in this setting.
format Online
Article
Text
id pubmed-6332814
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63328142019-01-17 Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature Shokr, Mohamed Ahmed, Abdelrahman Abubakar, Hossam Sayedahmad, Ziad Rashed, Ahmed Afonso, Luis Cardozo, Shaun Clin Case Rep Case Reports Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug‐drug interactions. Randomized controlled trials are needed to further demonstrate their efficacy and safety in this setting. John Wiley and Sons Inc. 2018-11-22 /pmc/articles/PMC6332814/ /pubmed/30656027 http://dx.doi.org/10.1002/ccr3.1917 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Shokr, Mohamed
Ahmed, Abdelrahman
Abubakar, Hossam
Sayedahmad, Ziad
Rashed, Ahmed
Afonso, Luis
Cardozo, Shaun
Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title_full Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title_fullStr Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title_full_unstemmed Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title_short Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
title_sort use of direct oral anticoagulants in the treatment of left ventricular thrombi: a tertiary center experience and review of the literature
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332814/
https://www.ncbi.nlm.nih.gov/pubmed/30656027
http://dx.doi.org/10.1002/ccr3.1917
work_keys_str_mv AT shokrmohamed useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT ahmedabdelrahman useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT abubakarhossam useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT sayedahmadziad useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT rashedahmed useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT afonsoluis useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature
AT cardozoshaun useofdirectoralanticoagulantsinthetreatmentofleftventricularthrombiatertiarycenterexperienceandreviewoftheliterature

Ejemplares similares